Page 2 - Obesity In India

Can Mounjaro transform obesity care? ₹50 crore sales in three months

Eli Lilly's Mounjaro has seen explosive growth since its March launch in India, with sales soaring to Rs 50 crore in three months

Can lemon water burn fat? Experts bust 15 weight loss myths you believe

From lemon water and detox drinks to skipping rice and sweating more, experts separate fat-loss facts from fiction to help you focus on what works

Anti-obesity mkt heats up as Mounjaro's Kwikpen version gets India approval

With CDSCO approval, Mounjaro to be available in a Kwikpen format; this comes a day after Wegovy's India launch, intensifying competition in weight-loss treatment

Novo Nordisk launches Wegovy in India to tackle obesity and heart risk

Wegovy is India's first weekly injectable approved for both long-term weight loss and reducing heart risks in obese and overweight adults

India's response to obesity drug Mounjaro 'positive', says Eli Lilly

Mounjaro has sold more than 81,570 units in India, totalling about ₹23.94 crore ($2.76 million) as of May, with the drug logging a 60 per cent rise in overall sales between April and May

Delhi schoolkids face surge in obesity and hypertension, warns Aiims study

A new Aiims study reveals a worrying rise in obesity, hypertension and hidden metabolic risks among Delhi schoolchildren, especially those in private schools

Novo Nordisk to launch weight-loss drug Wegovy in India ahead of schedule

Amid rising demand and Eli Lilly's Mounjaro launch, Novo Nordisk is advancing plans to introduce its obesity drug Wegovy in the Indian market

India's oil intake has tripled-how much is too much for your health?

India's per capita oil intake has jumped to 23.5 kg a year-nearly twice the ICMR's limit-raising health concerns over obesity, heart disease, and diabetes

Why Mounjaro's India entry has doctors and patients picking up the phone

With obesity on the rise, Eli Lilly's weight-loss injection triggers a rush of consultations as Indians seek safer, cheaper options to black-market drugs

Obesity cure is here? Why it could be a win-win for all stakeholders

We Indians have had a different perspective around obesity

Eli Lilly launches blockbuster anti-obesity drug Mounjaro in India. Prices here

Eli Lilly's much-anticipated drug for diabetes and obesity, that competes with Ozempic globally, is now in India. Here's what you need to know

Small cities, healthier appetite: Tier-III cities lead healthy food growth

According to Unicommerce, order volumes for healthy food staples and snacks surged by 60 per cent year-on-year

World Obesity Day 2025: Theme, history, significance, habits and more

Every year on March 4, people mark World Obesity Day with the goal of eradicating stigma and misconceptions regarding obesity and increasing public awareness about it

PM Modi picks Omar Abdullah, 9 others for nationwide anti-obesity drive

PM Modi nominates Omar Abdullah, 9 others for anti-obesity campaign, urging for a nationwide movement to reduce oil consumption and promote a healthier India

PM Modi's push for obesity fight draws praise from medical fraternity

Co-Chair of the CII Public Health Council and Director of ITC Healthcare, Dr Sunil Chandy, said that the Prime Minister's obesity is the new epidemic that is affecting the Indian population

Eli Lilly to launch its obesity drug at competitive price in India in 2025

Lilly's rival Danish firm Novo Nordisk is also working to bring its obesity drug Wegovy (Semaglutide) to India soon, and according to reports the company may launch Wegovy in 2026

Need to face up to junk food crisis as study shows 23% Indians overweight

Indians need simple, easy-to-understand, and prominent warning labels, so that their better natures are given a chance to overtake their impulses

Wealthy Indians jump through hoops to secure weight-loss drugs like Ozempic

Indi had the third largest number of people with obesity as of 2022, behind China and the US, according to a study in The Lancet, with numbers surging as junk food consumption becomes more commonplace

New oral diabetes and obesity drug sale doubles in India amid demand surge

The sales of Novo Nordisk's Rybelsus tablet, used for diabetes treatment and weight reduction, more than doubled to Rs 363 crore this year from Rs 147 crore last year

Biocon leads India's push into anti-obesity drugs as patents lapse

The company, helmed by Kiran Mazumdar Shaw, is leading the charge among Indian drugmakers - the world's largest supplier of generic medicines - as they race to grab a slice of the obesity drugs market